•
Jun 30, 2023

REGENXBIO Q2 2023 Earnings Report

Total Revenue
$20M
Previous year: $32.6M
-38.8%
EPS
-$1.66
Previous year: -$1.58
+5.1%
Gross Profit
$10.5M
Previous year: $19.7M
-46.7%
Cash and Equivalents
$68.6M
Previous year: $121M
-43.5%
Free Cash Flow
-$49.9M
Previous year: -$71M
-29.7%
Total Assets
$682M
Previous year: $953M
-28.4%

REGENXBIO

REGENXBIO